UK’s health and social care watchdog has decided against recommending Mounjaro, Eli Lilly’s weight loss drug for adults with diabetes.
The National Institute for Health and Care Excellence (NICE) in the UK released draft guidance stating that they need more information about tirzepatide, the active ingredient in Mounjaro.
